Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 39
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.08-026 - First Case of SMARCB1(INI1)- Deficient Squamous Cell Carcinoma of the Pleura
09:30 - 09:30 | Author(s): K. Yoshida
- Abstract
Loading... -
+
P1.08-028 - PD-L1 Expression in Neuroendocrine Tumors of the Lung
09:30 - 09:30 | Author(s): H. Horinouchi
- Abstract
Loading...
-
+
ORAL 01 - Chemotherapy Developments for Lung Cancer
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 7
- Moderators:G. Blumenschein
- Coordinates: 9/07/2015, 10:45 - 12:15, 401-404
-
+
ORAL01.01 - Randomized Phase III Study of Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel for Advanced Squamous Cell Lung Cancer (WJOG5208L)
10:45 - 10:56 | Author(s): T. Seto
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 17 - EGFR Mutant Lung Cancer
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 9
- Moderators:P. Meldgaard
- Coordinates: 9/08/2015, 10:45 - 12:15, Four Seasons Ballroom F3+F4
-
+
ORAL17.03 - Biomarkers for Efficacy in JO25567 Study Evaluating Erlotinib plus Bevacizumab versus Erlotinib in Advanced NSCLC with EGFR Mutation
11:07 - 11:18 | Author(s): S. Atagi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 91
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.01-080 - An Open-Label, Multicenter, Phase 1b/2 Study to Evaluate Necitumumab in Combination with Gemcitabine and Cisplatin in the First-Line Treatment of Patients with Advanced (Stage IV) Squamous Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): T. Tamura
- Abstract
Loading...
-
+
P3.07 - Poster Session/ Small Cell Lung Cancer
- Type: Poster
- Track: Small Cell Lung Cancer
- Presentations: 18
- Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P3.07-005 - Maintenance Irinotecan Therapy in Extensive Disease Small Cell Lung Cancer: A Feasibility Study
09:30 - 09:30 | Author(s): S. Yamamoto
- Abstract
Loading...
-
+
PC 03 - Pro vs Con: Prophylactic Cranial Irradiation (PCI) Post Chemotherapy Response / Pro vs Con: Is There a Role for Radiation in Oligometastatic Disease?
- Type: Pro Con
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 5
- Moderators:A. Brade
- Coordinates: 9/09/2015, 14:15 - 15:45, 708+710+712
-
+
PC03.02 - Prophylactic Cranial Irradiation (PCI) Post Chemotherapy Response - Con
14:40 - 15:00 | Author(s): N. Yamamoto
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 37 - SCLC Therapy
- Type: Mini Oral
- Track: Small Cell Lung Cancer
- Presentations: 13
- Moderators:D. Ettinger
- Coordinates: 9/09/2015, 18:30 - 20:00, 605+607
-
+
MINI37.06 - Randomized Phase II Trial of CODE or Amrubicin Plus Cisplatin Chemotherapy after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer
19:00 - 19:05 | Author(s): I. Sekine
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.